ELIZABETH ARVIZU: Open Payments
NPI 1265661110 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,495 in 121 payments from 39 companies in 2025. Trend: 2023 $485 · 2024 $2,292 · 2025 $2,495
Food & beverage: $2,495
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $198 |
| AstraZeneca Pharmaceuticals LP | 8 | $173 |
| Janssen Biotech, Inc. | 10 | $173 |
| Stemline Therapeutics Inc. | 5 | $116 |
| Astellas Pharma US Inc | 5 | $107 |
| Novartis Pharmaceuticals Corporation | 5 | $106 |
| GlaxoSmithKline, LLC. | 5 | $103 |
| Celgene Corporation | 4 | $99 |
| ABBVIE INC. | 4 | $83 |
Products named: KEYTRUDA, ICLUSIG, Orserdu, OJJAARA, EPKINLY, CABOMETYX, LONSURF, OPDIVO.
Industry payments across CA — which companies pay providers there.
